Abstract
Targeting a genetic variant with an antagonist may restore insulin secretion in a subgroup of type 2 diabetes patients (Tang et al., this issue).
Copyright © 2014, American Association for the Advancement of Science.
MeSH terms
-
Adrenergic alpha-2 Receptor Antagonists / therapeutic use*
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / genetics*
-
Female
-
Humans
-
Male
-
Receptors, Adrenergic, alpha-2 / genetics*
Substances
-
ADRA2A protein, human
-
Adrenergic alpha-2 Receptor Antagonists
-
Receptors, Adrenergic, alpha-2